Switch View
© Globe Newswire
15.10.2025
ISIN: US04301G1022
Artelo Biosciences, Inc.
ARTL
LISTED
NASDAQ
Artelo Biosciences Announces Expanded Clinical Data to be Presented on both ART26.12 and ART27.13 at the 8th Annual Cannabinoid & Endocannabinoid Drug Development Summit
News Preview
ART26.12 Phase 1 Data Demonstrated No Safety Concerns, Predictable Linear Plasma Exposure, and Options for Dosing in Either Fed or Fasted Conditions ...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US75901B1070
Regenxbio Inc
RGNX
LISTED
NASDAQ
REGENXBIO to Participate in Upcoming Investor Conferences
News Preview
ROCKVILLE, Md., Oct. 15, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following investor conferences:
Chardan's 9th Annual Genetic Medicines Conference
Panel "Battleground States for Muscular Dystrophies": Tuesd...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
ISIN: US86627T1088
Summit Therapeutics Inc
SMMT
LISTED
NASDAQ
Summit Therapeutics to Host ESMO Data Update & Third Quarter Earnings Call on October 20, 2025
News Preview
Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) will host an ESMO Data Update and Third Quarter Earnings Call on Monday, October 20, 2025, before the market opens. The ESMO data relates to the planned disclosure of the HARMONi-6 clinical trial data.
As a reminder, the Phase III HARMONi-6 trial, conducted in China and s...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
15.10.2025
ISIN: US68752M1080
Orthofix Medical Inc
OFIX
LISTED
NASDAQ
Orthofix to Participate in Upcoming Investor Conferences
News Preview
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that Massimo Calafiore, President and Chief Executive Officer, and Julie Andrews, Chief Financial Officer, will participate in the following investor conferences:
UBS Global Healthcare Conference in Palm Beach Gardens, FL, November 11, 2025, at 1:1...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
15.10.2025
ISIN: US98978V1035
Zoetis Inc
ZTS
LISTED
NYSE
Zoetis Announces Health Canada Approval of Lenivia® (izenivetmab injection) for Alleviation of Osteoarthritis (OA) Pain in Dogs
News Preview
Zoetis Inc. today announced that Health Canada has approved Lenivia® (izenivetmab injection) for the alleviation of pain associated with osteoarthritis (OA) in dogs. Built on a decade of science and research, Lenivia is a new antibody therapy with a safety profile demonstrated in a nine-month field study where dogs receiving Lenivia experienced in...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
ISIN: JE00BYSS4X48
Novocure Ltd
NVCR
LISTED
NASDAQ
Novocure to Present New Research for Tumor Treating Fields (TTFields) Therapy at European Association of Neuro-Oncology (EANO) Meeting and the European Society for Medical Oncology (ESMO) Congress
News Preview
Novocure (NASDAQ: NVCR) announced today that it will present data at two upcoming oncology congresses, the 2025 European Association of Neuro-Oncology (EANO) Meeting, being held October 16-19 in Prague, Czech Republic, and the European Society for Medical Oncology (ESMO) Congress 2025, being held October 17-21 in Berlin, Germany.
At the EANO 202...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
ISIN: US91307C1027
United Therapeutics Corp
UTHR
LISTED
NASDAQ
United Therapeutics Corporation to Report Third Quarter 2025 Financial Results Before Market Open on Wednesday, October 29, 2025
News Preview
United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its third quarter 2025 financial results before the market opens on Wednesday, October 29, 2025. A press release detailing the quarterly results will be issued that day at approximately 6:30 a.m. Eastern Time.
United Therapeutics will host a public webcast Wednesd...
Themefolio
Profiler
Peergroup
© Newsfile
15.10.2025
ISIN: US49721T3095
Kiora Pharmaceuticals, Inc.
KPRX
LISTED
NASDAQ
Kiora Pharmaceuticals to Participate in the 2025 Maxim Growth Summit and Eyecelerator @ AAO 2025
News Preview
Encinitas, California--(Newsfile Corp. - October 15, 2025) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) today announced that it will participate in an ophthalmology panel at the upcoming 2025 Maxim Growth Summit in New York and give an overview of its development pipeline at Eyecelerator @ AAO 2025 in Orlando. Maxim Growth Summit Ophthalmology Pane...
Themefolio
Profiler
Peergroup
© Newsfile
15.10.2025
ISIN: CA2046632071
Comprehensive Healthcare Systems Inc.
CHS
LISTED
TSX
Comprehensive Healthcare Systems Inc. Signs Memorandum of Understanding with Large Health Insurance Administrator for a Five-Year Partnership
News Preview
Vancouver, British Columbia--(Newsfile Corp. - October 15, 2025) - Comprehensive Healthcare Systems Inc. (TSXV: CHS) (the "Company" or "CHS"), an industry leader in healthcare benefits administration software and services, is pleased to announce the signing of a non-binding Memorandum of Understanding (MOU) with a large health insurance benefits ad...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US4576693075
Insmed Inc
INSM
LISTED
NASDAQ
Insmed to Host Third-Quarter 2025 Financial Results Conference Call on Thursday, October 30, 2025
News Preview
BRIDGEWATER, N.J., Oct. 15, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it will release its third-quarter 2025 financ...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US09073M1045
Bio-Techne Corp
TECH
LISTED
NASDAQ
Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results
News Preview
MINNEAPOLIS, Oct. 15, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, November 5, 2025, at 8:00 a.m. CST to review its first quarter fiscal 2026 financial results.
Access to the discussion may be obtai...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
Merck Announces New Data from Phase 3 Trials Evaluating the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) in Adults with Virologically Suppressed HIV-1 Infection
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the presentation of additional data from the Phase 3 studies of the investigational, once-daily, oral, two-drug regimen of doravirine/islatravir [DOR/ISL (100mg/0.25mg)] in adults with HIV-1 infection that was virologically suppressed on bictegravir/emtricitab...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
15.10.2025
ISIN: US6373722023
National Research Corp
NRC
LISTED
NASDAQ
NRC Health Honors 2025 Leaders in Patient Experience and Loyalty
News Preview
NRC Health, the leading partner in Healthcare Experience Management, is proud to announce the recipients of its 2025 Consumer Loyalty Awards, Excellence in Patient Experience Awards, and Excellence in Experience Management Award.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251015788...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US5324571083
Eli Lilly and Co
LLY
LISTED
NYSE
Lilly's oral GLP-1, orforglipron, demonstrated superior glycemic control in two successful Phase 3 trials, reconfirming its potential as a foundational treatment in type 2 diabetes
News Preview
In ACHIEVE-2, orforglipron lowered A1C by up to 1.7% compared to 0.8% with
dapagliflozin, meeting the primary endpoint
In ACHIEVE-5, orforglipron lowered A1C by an additional 2.1% when taken with insulin glargine, meeting the primary endpoint...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: DK0062498333
Novo Nordisk A/S
NOVO B
LISTED
CPH
Novo Nordisk and Omeros announce asset purchase and license agreement for Omeros’ clinical-stage MASP-3 inhibitor zaltenibart (OMS906)
News Preview
Bagsværd, Denmark and Seattle, US, 15 October 2025 – Novo Nordisk and Omeros Corporation (Nasdaq: OMER) today announced that they have entered into a definitive asset purchase and license agreement for the candidate drug zaltenibart (formerly OMS906) in clinical development for rare blood and kidney disorders....
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US71902K1051
CERo Therapeutics Holdings, Inc.
CERO
LISTED
NASDAQ
CERo Therapeutics to Participate in Stem Cell Therapy Panel at the Maxim Growth Summit 2025
News Preview
SOUTH SAN FRANCISCO, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo” or the “Company”), an innovative cellular immunotherapy company, announces that Chris Ehrlich, Chief Executive Officer will participate in a stem cell therapy panel titled, “A Space That is Ready to Have its Day,” at the Maxim G...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US18914F1030
Clover Health Investments Corp
CLOV
LISTED
NASDAQ
Clover Health’s 2026 Medicare Advantage Plans Champion Affordability and Choice
News Preview
The Company Reinforces Market Position, Maintaining Comprehensive PPO Portfolio As Clover Assistant Drives Sustainable Value The Company Reinforces Market Position, Maintaining Comprehensive PPO Portfolio As Clover Assistant Drives Sustainable Value...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: CA82621K1021
Sienna Senior Living Inc
SIA
LISTED
TSX
Sienna Announces October Dividend
News Preview
MARKHAM, Ontario, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “Common Share”) for the month of October 2025, representing $0.936 per Common Share on an annualized basis....
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Wellcare Enhances Offering of Affordable, Quality Medicare Advantage and Medicare Prescription Drug Plans in 2026
News Preview
Medicare Advantage plans will be available to more than 51 million beneficiaries in 32 states; Prescription Drug Plans will continue to be offered nationwide
New in 2026:
Wellcare to transition Medicare-Medicaid Plans (MMPs) demonstrations to...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
ISIN: CA05156V1022
Aurinia Pharmaceuticals Inc
AUPH
LISTED
NASDAQ
Aurinia Announces Upcoming Presentations of New Data on LUPKYNIS® at American College of Rheumatology Convergence and American Society of Nephrology Kidney Week 2025
News Preview
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced that five posters will be presented in collaboration with independent investigators highlighting new data on LUPKYNIS® (voclosporin) at the American College of Rheumatology (ACR) Convergence 2025, taking place in Chicago, IL, October 24–29, and the American Society of Nephrology (ASN) Kid...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
ISIN: US7743743004
Rockwell Medical Inc
RMTI
LISTED
NASDAQ
Rockwell Medical to Release Third Quarter 2025 Results on Wednesday, November 12, 2025
News Preview
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the third quarter ended September 30, 2025 on Wednesday, Novemb...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US6024961012
MiMedx Group Inc
MDXG
LISTED
NASDAQ
MIMEDX to Host Third Quarter 2025 Operating and Financial Results Conference Call on October 29
News Preview
MARIETTA, Ga., Oct. 15, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the third quarter ended September 30, 2025 after the market close on Wednesday, October 29, 2025. The MIMEDX senior management team will host a webcast and confe...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: CA3018351047
Extendicare Inc
EXE
LISTED
TSX
Extendicare Announces October 2025 Dividend of C$0.042 per Share
News Preview
MARKHAM, Ontario, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.042 per common share of the Company for the month of October 2025, which is payable on November 17, 2025 to shareholders of record at the close of business on October 31, 2025. This...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US00091E1091
Absci Corp
ABSI
LISTED
NASDAQ
Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial
News Preview
Webinar on December 11 to feature leading KOLs in dermatology and hair loss alongside Absci leadership...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US61023L1089
Monopar Therapeutics Inc
MNPR
LISTED
NASDAQ
Monopar Announces Abstract Accepted for Oral Presentation at AASLD - The Liver Meeting® 2025
News Preview
WILMETTE, Ill., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today announced that its abstract on the Phase 2 ALXN1840-WD-204 copper balance study has been selected for an o...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Wellcare Enhances Offering of Affordable, Quality Medicare Advantage and Medicare Prescription Drug Plans in 2026
News Preview
Medicare Advantage plans will be available to more than 51 million beneficiaries in 32 states; Prescription Drug Plans will continue to be offered nationwide
New in 2026: Wellcare to transition Medicare-Medicaid Plans (MMPs) demonstrations to integrated Dual Eli...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US85916J4094
Stereotaxis Inc
STXS
LISTED
XASE
Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs
News Preview
ST. LOUIS, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it obtained CE Mark in Europe and submitted a 510(k) application to the FDA in the US for the Synchrony™ system....
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US7599161095
Repligen Corp
RGEN
LISTED
NASDAQ
Repligen to Report Third Quarter 2025 Financial Results
News Preview
Webcast and Conference Call to Be Held Tuesday, October 28, 2025, at 8:30 a.m. ET Webcast and Conference Call to Be Held Tuesday, October 28, 2025, at 8:30 a.m. ET...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US75886F1075
Regeneron Pharmaceuticals Inc
REGN
LISTED
NASDAQ
Regeneron Showcases Advances Across Oncology Portfolio and Pipeline at ESMO, Highlighting Novel and Patient-Focused Approach for Difficult-to-Treat Cancers
News Preview
New safety and pharmacokinetic data from Phase 3 C-POST trial provide insights on an every 6-week dosing regimen of adjuvant Libtayo® (cemiplimab) in high-risk cutaneous squamous cell carcinoma New safety and pharmacokinetic data from Phase 3 C-POST trial provide insights on an every 6-week dosing regimen of adjuvant Libtayo® (cemiplimab) in high-r...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US34965KAA51
Fortrea Holdings, Inc.
FTRE
LISTED
NASDAQ
Fortrea Announces Date for Third Quarter 2025 Financial Results and Conference Call
News Preview
DURHAM, N.C., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its third quarter 2025 financial results before the market opens on Wednesday, November 5, 2025. Fortrea will host a conference call at 8:00 am ET that day to review it...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: CA01559R1038
Algernon Pharmaceuticals Inc.
AGN
LISTED
CSE
Algernon Pharmaceuticals Completes Name Change to Algernon Health
News Preview
VANCOUVER, British Columbia, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company announces that it has completed its previously announced name change to Algernon Health Inc. The Company’s common shares will begin trading under the...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US4037831033
Gyre Therapeutics Inc
CBIO
LISTED
NASDAQ
Gyre Therapeutics Announces Completion of Patient Enrollment in Phase 3 Clinical Trial of Pirfenidone Capsules for the Treatment of Pneumoconiosis
News Preview
Gyre Therapeutics Announces Completion of Patient Enrollment in Phase 3 Clinical Trial of Pirfenidone Capsules for the Treatment of Pneumoconiosis...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US4923271013
Keros Therapeutics Inc
KROS
LISTED
NASDAQ
Keros Therapeutics Announces Plan for Return of $375 Million in Excess Capital
News Preview
Agrees to Repurchase of All Shares Held By ADAR1 Capital Management and Pontifax Venture Capital...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US09075X1081
Biodesix Inc
BDSX
LISTED
NASDAQ
Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting
News Preview
One year after launch of real-world CLARIFY study, preliminary data from the first 1,000 enrolled patients will be presented One year after launch of real-world CLARIFY study, preliminary data from the first 1,000 enrolled patients will be presented...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: FR0000120578
Sanofi SA
SAN
LISTED
EURONEXT
Communiqué de presse : Sanofi fait de Montpellier le coeur mondial de la recherche translationnelle sur les maladies auto-immunes
News Preview
Sanofi fait de Montpellier le coeur mondial de la recherche translationnelle sur les maladies auto-immunes...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
ISIN: US3755581036
Gilead Sciences Inc
GILD
LISTED
NASDAQ
Gilead Presents New HIV Research Data at EACS 2025 – Driving Scientific Innovation in Treatment and Prevention
News Preview
Gilead Sciences, Inc. (Nasdaq: GILD) today announced its upcoming participation in the 20th European AIDS Conference (EACS) to be held in Paris, France from October 15-18. As the leader in HIV innovation, Gilead will provide an update on its strategic initiatives, key collaborations, and share new scientific data from its HIV research and developm...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
15.10.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
Medical Care Technologies Inc. (OTC PINK:MDCE) Expands App Library With New AI Health App Ecosystem Targeting the Explosive $400 Billion Digital Health Industry
News Preview
MESA, ARIZONA / ACCESS Newswire / October 15, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced the development of a suite of AI-powered consumer applications focused on diet, fitness, and preventive health. The company expects to release its first public app before year-end 2025, with its flagship medical-grade AI platform scheduled...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: KYG6464H1011
Newborn Town Inc.
9911
LISTED
HKSE
Newborn Town Receives HK$17.50 Target Price, with Strong Localization Edge Outperforming U.S. and China Peers
News Preview
HONG KONG, Oct. 15, 2025 /PRNewswire/ -- Newborn Town, the global social entertainment company, has been given a target price of HK$17.50 and an "Outperform" rating in a recent report from CLSA.
Compared with the closing price of HK$11.66 on 10 October, CLSA's target price implies an upside...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
MOH Investors Have Opportunity to Lead Molina Healthcare, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Oct. 15, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Molina Healthcare, Inc. ("Molina" or "the Company") (NYSE: MOH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
Molina Healthcare, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MOH
News Preview
LOS ANGELES, Oct. 15, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Molina Healthcare, Inc. ("Molina " or "the Company") (NYSE: MOH ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securiti...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
15.10.2025
ISIN: US6300872032
NanoViricides, Inc.
NNVC
LISTED
XASE
NanoViricides Dual Track Clinical Strategy Explained by a Research Report - Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage for MPox and also for Acute Respiratory Infections of All Viruses
News Preview
SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that an analyst research report was published on the Company that explains its dual-track, rapid clinical development strategy for NV-387, going after MPox and also after all respiratory viral infections, that incl...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
15.10.2025
ISIN: CA00143Y1034
AI-ML Innovations Inc.
AIML
LISTED
CSE
AIML Subsidiary NeuralCloud Solutions and Heartdent Center Ltd. Launch Pilot Project to Advance Cardiac Care in Jamaica
News Preview
Pilot Study to Lay the Groundwork for Expansion Across JamaicaGoal of the Collaboration is to Demonstrate the Ability to Deliver Affordable, Accurate, and Scalable Holter Diagnostics with CardioYield™ TORONTO, ON, AB / ACCESS Newswire / October 15, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AI...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme-- Hagens Berman
News Preview
SAN FRANCISCO, Oct. 14, 2025 /PRNewswire/ -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating a deceptive billing strategy to artificially boost its financia...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US2358511028
Danaher Corp
DHR
LISTED
NYSE
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR
News Preview
NEW YORK, Oct. 14, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Corporation (NYSE: DHR)....
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
ISIN: KR7475830006
Orum Therapeutics, Inc.
475830
LISTED
KOE
Orum Therapeutics Appoints Dr. Dorin Toader as Head of Platform Technology to Advance Orum’s Degrader–Antibody Conjugate Payload Platforms and Expand TPD²® Therapeutic Applications
News Preview
Orum Therapeutics (“Orum” or the “Company”) (KRX: 475830), a public biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today announced the appointment of Dorin Toader, Ph.D., as Head of Platform Technology. Dr. Toader brings more than 27 years of experience in drug discovery, including over 15 years in antibody-drug...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US04635X1028
Astria Therapeutics Inc
ATXS
LISTED
NASDAQ
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Astria Therapeutics, Inc. (NASDAQ: ATXS)
News Preview
NEW YORK, Oct. 14, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquarte...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2025
ISIN: US30233G2093
EyePoint Pharmaceuticals Inc
EYPT
LISTED
NASDAQ
EyePoint Announces Pricing of Public Offering
News Preview
WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced the pricing of an underwritten public offering of 11,000,000 shares of its common stock at...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: JP3942400007
Astellas Pharma Inc
45030
LISTED
XJPX
Astellas to Present First Real-World VEOZAH™ (fezolinetant) Data at 2025 Annual Meeting of The Menopause Society
News Preview
TOKYO, Oct. 14, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that VEOZAH™ (fezolinetant), its first-in-class, targeted, non-hormonal treatment for moderate to severe vasomotor symptoms (VMS) due to menopause, will be featured in six Astellas-s...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US98986M1036
Zynex Inc
ZYXI
LISTED
NASDAQ
Zynex Announces Appointment of Bret Wise to Board of Directors as Audit Committee Chair
News Preview
ENGLEWOOD, Colo., Oct. 14, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the appointment of Bret Wise to its Board of Di...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: AILIASX02567
BrightSpring Health Services Inc
BTSG
LISTED
NASDAQ
BrightSpring Health Services Set to Join S&P SmallCap 600
News Preview
NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, October 20. S&P 500 constituent Huntington Bancshares Inc. (NASD: HBAN) is acquiring Veritex H...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
Molina Healthcare, Inc. (MOH) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
BENSALEM, Pa., Oct. 14, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Molina Healthcare, Inc. ("Molina" or the "Company") (NYSE: MOH).
IF YOU ARE...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US9467841055
Waystar Holding Corp.
WAY
LISTED
NASDAQ
Waystar to Announce Third Quarter 2025 Financial Results on October 29, 2025
News Preview
LEHI, Utah and LOUISVILLE, Ky., Oct. 14, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, announced today that it will report financial results for the third quarter ended September 30, 2025, after market close on Wednesday, October 29, 2025. The company...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Nutex Health Inc. (NUTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
BENSALEM, Pa., Oct. 14, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX).
IF YOU ARE AN...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US4523271090
Illumina Inc
ILMN
LISTED
NASDAQ
Illumina to Announce Third Quarter 2025 Financial Results on Thursday, October 30, 2025
News Preview
SAN DIEGO, Oct. 14, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for the third quarter 2025 following the close of market on Thursday, October 30, 2025.
On the same day, at 1:30 pm Pacific Time (4:30 pm Eastern Time) Jacob Thaysen, PhD, Chief Execu...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: CA60255C8850
Mind Medicine (MindMed) Inc
MNMD
LISTED
NASDAQ
MindMed Announces New Employee Inducement Grant
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to one newly hired non-executive employee consisting of an option to purchase 28,000 common shares of the Co...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
CYTK Investors Have Opportunity to Lead Cytokinetics, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 14, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. (NASDAQ:...
Themefolio
Profiler
Peergroup
© Newsfile
14.10.2025
ISIN: CA0909741062
BioNxt Solutions Inc.
BNXT
LISTED
CSE
CSE Bulletin: MOC Eligibility Update
News Preview
Toronto, Ontario--(Newsfile Corp. - October 14, 2025) - The following CSE-Listed symbol will become MOC Eligible as detailed below. Symbol Company Name Effective Date BNXT...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US3795772082
Globus Medical Inc
GMED
LISTED
NYSE
Globus Medical Launches ANTHEM™ Elbow Fracture System: A Comprehensive Plating Portfolio for Complex Elbow Trauma
News Preview
AUDUBON, Pa., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, has announced the launch of the ANTHEM™ Elbow Fracture System, a fully comprehensive plating portfolio designed to address a wide spectrum of elbow fractures....
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US30233G2093
EyePoint Pharmaceuticals Inc
EYPT
LISTED
NASDAQ
EyePoint Announces Proposed Public Offering of Common Stock
News Preview
WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that it has commenced an underwritten public offering of $150 million of shares of its comm...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
Broadwood Partners Comments on STAAR Surgical’s Late and Troubling Disclosure in Deeply Flawed Sale Process to Alcon
News Preview
Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today commented on the recent Current Report on Form 8-K filed by STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) with the U.S. Securities and Exchange Commission (“SEC”) of a “supplement” to the Company’s definitive proxy statement, filed on September 16, 2025, in...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
